Literature DB >> 81059

Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.

N Sakamoto, M Terai, T Takenaka, H Maeno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81059     DOI： 10.1016/0006-2952(78)90462-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  In vivo analysis of compound activity and mechanism of action using epistasis in Drosophila.

Authors:  Erdem Bangi; Dan Garza; Marc Hild
Journal:  J Chem Biol       Date:  2010-12-22

2.  Nicardipine releases sustained coronary arterial constriction induced by acetylcholine in the rhesus monkey.

Authors:  K Satoh; M Kawada; Y Wada; N Taira
Journal:  Heart Vessels       Date:  1985-05       Impact factor: 2.037

Review 3.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

4.  Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.

Authors:  J Bonnet; A M Loiseau; M Orvoen; P Bessin
Journal:  Agents Actions       Date:  1981-12

5.  Cardiovascular pharmacology of nicardipine in animals.

Authors:  T Takenaka; M Asano; K Shiono; M Shibasaki; O Inagaki
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers.

Authors:  Y D Ko; A Sachinidis; G H Graack; M Appenheimer; A J Wieczorek; R Düsing; H Vetter
Journal:  Clin Investig       Date:  1992-02

7.  Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.

Authors:  P Bellemann; A Schade; R Towart
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

8.  A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities.

Authors:  Rugmani Padmanabhan Iyer; Merry L Lindsey; Robert J Chilton
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.